gyki 52466 has been researched along with Angiospasm, Intracranial in 1 studies
GYKI 52466: an AMPA (non-NMDA) receptor antagonist; structure given in first source
Excerpt | Relevance | Reference |
---|---|---|
"The pathogenesis and treatment of cerebral vasospasm (CV) after subarachnoid hemorrhage (SAH) remains a matter of discussion." | 1.35 | Effects of GYKI 52466 on early vasospasm in rats. ( Akdemir, O; Colak, A; Karaoglan, A; Kokturk, S; Sagmanligil, A; Soy, O; Tasyurekli, M, 2009) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Colak, A | 1 |
Soy, O | 1 |
Karaoglan, A | 1 |
Akdemir, O | 1 |
Kokturk, S | 1 |
Sagmanligil, A | 1 |
Tasyurekli, M | 1 |
1 other study available for gyki 52466 and Angiospasm, Intracranial
Article | Year |
---|---|
Effects of GYKI 52466 on early vasospasm in rats.
Topics: Animals; Benzodiazepines; Excitatory Amino Acid Antagonists; Femoral Artery; Microscopy, Electron, T | 2009 |